FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059706629> ?p ?o ?g. }

• W2059706629 endingPage "649" @default.
• W2059706629 startingPage "641" @default.
• W2059706629 abstract "Myeloablative doses of BU and fludarabine followed by allogeneic hematopoietic cell transplantation offer effective therapy for AML. We anticipated that pharmacokinetic targeting of i.v. BU to 5300 μ/L min/day × 4 (targeted i.v. BU and fludarabine (t-i.v. BU/Flu)) would limit nonrelapse mortality (NRM) in adults up to 70 years of age. We assessed the safety and efficacy of t-i.v. BU/Flu in a series of 100 adults (median age 48, range 22–69 years) with AML in the first CR (CR1) with high risk of treatment failure (n=49), second CR (CR2, n=25), relapsed disease (REL, n=9), primary induction failure (PIF, n=16) and untreated (n=1). NRM was 3% at 100 days and 15% at 1 year. The cumulative incidence of relapse was 30.6% for CR1, 41.7% for CR2, 55.6% for REL and 58.6% for PIF. OS for primary AML in CR1 was 66% (95% confidence interval (CI): 46–80%) at 1 year, and 62% (95% CI: 42–77%) at 2 years. On multivariable modeling, remission status, moderate/severe chronic GVHD and day-90 BM chimerism ⩾90% predicted improved OS. Importantly, there was no effect of age. t-i.v. BU/Flu provides effective disease control with encouraging NRM in patients up to age of 70 years." @default.
• W2059706629 created "2016-06-24" @default.
• W2059706629 creator A5004386819 @default.
• W2059706629 creator A5012866839 @default.
• W2059706629 creator A5023535165 @default.
• W2059706629 creator A5035905546 @default.
• W2059706629 creator A5056360950 @default.
• W2059706629 creator A5060783496 @default.
• W2059706629 creator A5068862906 @default.
• W2059706629 creator A5077963733 @default.
• W2059706629 creator A5083349008 @default.
• W2059706629 date "2010-08-16" @default.
• W2059706629 modified "2023-10-07" @default.
• W2059706629 title "Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicity" @default.
• W2059706629 cites W1274344746 @default.
• W2059706629 cites W1492609361 @default.
• W2059706629 cites W1910981723 @default.
• W2059706629 cites W1965979673 @default.
• W2059706629 cites W1970298901 @default.
• W2059706629 cites W1972674500 @default.
• W2059706629 cites W1977384601 @default.
• W2059706629 cites W1982888691 @default.
• W2059706629 cites W1990247501 @default.
• W2059706629 cites W1992090010 @default.
• W2059706629 cites W1995851214 @default.
• W2059706629 cites W2001895625 @default.
• W2059706629 cites W2014751151 @default.
• W2059706629 cites W2018603311 @default.
• W2059706629 cites W2033987705 @default.
• W2059706629 cites W2035515789 @default.
• W2059706629 cites W2038981426 @default.
• W2059706629 cites W2040886821 @default.
• W2059706629 cites W2041150576 @default.
• W2059706629 cites W2042888665 @default.
• W2059706629 cites W2046464784 @default.
• W2059706629 cites W2060311019 @default.
• W2059706629 cites W2073140442 @default.
• W2059706629 cites W2074425311 @default.
• W2059706629 cites W2079167213 @default.
• W2059706629 cites W2084267226 @default.
• W2059706629 cites W2094729406 @default.
• W2059706629 cites W2096793413 @default.
• W2059706629 cites W2103529718 @default.
• W2059706629 cites W2106947293 @default.
• W2059706629 cites W2115750869 @default.
• W2059706629 cites W2118322536 @default.
• W2059706629 cites W2118693086 @default.
• W2059706629 cites W2121945260 @default.
• W2059706629 cites W2126744035 @default.
• W2059706629 cites W2127080762 @default.
• W2059706629 cites W2130695394 @default.
• W2059706629 cites W2136016420 @default.
• W2059706629 cites W2146910383 @default.
• W2059706629 cites W2147773887 @default.
• W2059706629 cites W2151704978 @default.
• W2059706629 cites W2158682205 @default.
• W2059706629 cites W2162927689 @default.
• W2059706629 cites W2167517686 @default.
• W2059706629 cites W2171267773 @default.
• W2059706629 cites W2276362528 @default.
• W2059706629 cites W2315152253 @default.
• W2059706629 cites W2334769895 @default.
• W2059706629 cites W2618073389 @default.
• W2059706629 cites W4244166141 @default.
• W2059706629 cites W4253640445 @default.
• W2059706629 doi "https://doi.org/10.1038/bmt.2010.190" @default.
• W2059706629 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5726256" @default.
• W2059706629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20711242" @default.
• W2059706629 hasPublicationYear "2010" @default.
• W2059706629 type Work @default.
• W2059706629 sameAs 2059706629 @default.
• W2059706629 citedByCount "22" @default.
• W2059706629 countsByYear W20597066292012 @default.
• W2059706629 countsByYear W20597066292013 @default.
• W2059706629 countsByYear W20597066292014 @default.
• W2059706629 countsByYear W20597066292015 @default.
• W2059706629 countsByYear W20597066292016 @default.
• W2059706629 countsByYear W20597066292017 @default.
• W2059706629 countsByYear W20597066292018 @default.
• W2059706629 countsByYear W20597066292019 @default.
• W2059706629 countsByYear W20597066292021 @default.
• W2059706629 countsByYear W20597066292022 @default.
• W2059706629 countsByYear W20597066292023 @default.
• W2059706629 crossrefType "journal-article" @default.
• W2059706629 hasAuthorship W2059706629A5004386819 @default.
• W2059706629 hasAuthorship W2059706629A5012866839 @default.
• W2059706629 hasAuthorship W2059706629A5023535165 @default.
• W2059706629 hasAuthorship W2059706629A5035905546 @default.
• W2059706629 hasAuthorship W2059706629A5056360950 @default.
• W2059706629 hasAuthorship W2059706629A5060783496 @default.
• W2059706629 hasAuthorship W2059706629A5068862906 @default.
• W2059706629 hasAuthorship W2059706629A5077963733 @default.
• W2059706629 hasAuthorship W2059706629A5083349008 @default.
• W2059706629 hasBestOaLocation W20597066292 @default.
• W2059706629 hasConcept C120665830 @default.
• W2059706629 hasConcept C121332964 @default.
• W2059706629 hasConcept C126322002 @default.
• W2059706629 hasConcept C141071460 @default.

• next